MediGene Signs Agreement with Meditrina for the Commercialization of Veregen in Greece and Cyprus
By Frontier India Pharmacetuicals News | April 1st, 2010 | Category: Europe Medical News, Latest | No Comments »The biotech company MediGene AG (Frankfurt, Prime Standard, TecDAX) has signed a license and supply agreement with Meditrina Pharmaceuticals for the supply and commercialization of VeregenĀ® in Greece and Cyprus. Meditrina will promote and distribute VeregenĀ® for the treatment of genital warts in both territories. Upon the achievement of specific milestones, MediGene will be entitled [...]


